Cue Biopharma Inc EV/Sales
What is the EV/Sales of Cue Biopharma Inc?
The EV/Sales of Cue Biopharma Inc is 1.08
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc
What does Cue Biopharma Inc do?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Companies with ev/sales similar to Cue Biopharma Inc
- Global Strategic has EV/Sales of 1.08
- Health and Happiness (H&H) International has EV/Sales of 1.08
- Shun Ho has EV/Sales of 1.08
- Boral has EV/Sales of 1.08
- Tri Pointe Homes has EV/Sales of 1.08
- Beasley Broadcast Inc has EV/Sales of 1.08
- Cue Biopharma Inc has EV/Sales of 1.08
- Sree Rayalaseema Hi-Strength Hypo has EV/Sales of 1.09
- Mondi Plc has EV/Sales of 1.09
- Inventis has EV/Sales of 1.09
- Controladora Vuela Cia De Aviacion has EV/Sales of 1.09
- Western Services has EV/Sales of 1.09
- Rici Healthcare has EV/Sales of 1.09